As Louisiana HB 592 moves through legislature, Texas’ workers’ compensation system is again the center of national discussion. Texas Commissioner Ryan Brennan doubled down on advocacy for other states to adopt the Texas-model formulary proclaiming it “a model for the nation” and “the inspiration for many other states’ proposed formularies” citing improvements in return-to-work, medical costs and access to care. Surely, a system as unique as Texas relies on more than a binary list of drugs to accomplish the outcomes documented in its 2016 biennial report. Here is “The Truth Regarding Outcomes in Texas and the Guideline Never Discussed”. Due to reference of the Texas Labor Code, I welcome feedback specifically from the legal community on this piece.
Month: May 2017
Why Details Matter for Louisiana in the Formulary Debate
The debate in Louisiana on a drug formulary continues. While HB 592 is being sent to House floor for a vote early next week, HB 529 remains in waiting. Here are my thoughts on why the Texas-model may not produce the expected results in Louisiana.